How many clicks does 2.5mg Mounjaro take on the KwikPen?

Why there are two clicks, not one

The Mounjaro KwikPen was designed with a two-stage injection mechanism across all its strengths. The first click begins the mechanical release of the dose; the second signals that the full volume has been delivered. Holding the pen in place between click one and click two is not optional, lifting away too early can leave part of the dose in the device rather than under the skin.

At 2.5mg specifically, the volume injected is small. That makes the ten-second hold after the second click particularly useful: it lets the small amount of fluid disperse from the needle tip before you withdraw. Skipping it can cause a tiny bead of medicine to appear at the injection site, which looks alarming but is mostly just wasted dose.

For a practical check you can do in under a minute: before every injection, glance at the dose window on the side of the pen and confirm it shows "2.5" clearly. If the window is blank, obscured or shows a different number, put the pen down and call your pharmacy. That one habit rules out a surprising number of errors.

The NHS tirzepatide medicines page covers the general injection process and links through to the Patient Information Leaflet, which has the definitive step-by-step with diagrams.

The decision your prescriber already made about this dose

A question our prescribers hear fairly often is whether 2.5mg will "do anything" for weight loss. The honest answer is that it is not designed to, not yet. The 2.5mg dose exists in the licensed titration schedule as an adjustment period, letting the gut adapt to the medicine before the prescriber moves you toward doses where the clinical effect on weight becomes meaningful.

That distinction matters if you are wondering whether you clicked correctly and the dose is working. At 2.5mg, reduced appetite or early fullness is possible, but the main job of this first pen is tolerability. Side effects, if they appear at all, are most commonly gastrointestinal: nausea, loose stools, or a general feeling of fullness that arrives earlier at mealtimes. These tend to settle within a week or two for most people.

If you are curious about what changes when the dose increases, the 5mg Mounjaro page covers what the next step looks like in practice. And if you are trying to work out the click count for a higher-strength pen, the two-click rule applies there too, you can read the specifics for the 5mg KwikPen or the 7.5mg pen separately.

When you are on a 7.5mg pen and using it for a 2.5mg dose

This is a genuinely common situation, and it catches people out. The standard 2.5mg KwikPen is pre-set at the factory: you cannot dial a dose, and the two-click sequence always delivers 2.5mg. However, some patients are dispensed a higher-strength pen (typically a 7.5mg pen) and asked by their prescriber to take a 2.5mg portion of it during a supply or transition period.

If that applies to you, the click count and dose volume are not the same as on a dedicated 2.5mg pen. The mechanics differ between pen formats. We have a separate, detailed page on using a 7.5mg pen to take a 2.5mg dose that covers exactly this scenario. Do not assume the two-click rule transfers directly without reading it.

For context on the full range of pen formats and what makes Mounjaro a dual-agonist medicine, the Mounjaro overview page is a good starting point. If you are thinking about getting a prescription through a regulated online pharmacy, the process always starts with a clinical consultation.

What to do if something feels off during the injection

Two clicks and a ten-second pause is the normal experience. But pens occasionally behave unexpectedly: a click that sounds quiet, a plunger that feels unusually stiff, or a dose window that does not move as expected. These are worth taking seriously, because a failed injection that looks complete is not the same as one that actually delivered the dose.

The right response is not to inject again immediately. Contact your prescribing pharmacy before making any decision about a replacement dose or a retry, because doubling a dose (even at 2.5mg) is not something to improvise. The clinical team at nume offers aftercare seven days a week for exactly this kind of situation.

Side effects that are severe or that do not follow the expected mild-and-settling pattern should be discussed with a prescriber. You can also report unexpected reactions to the MHRA directly through the Yellow Card scheme. If you want to understand the side-effect profile before you start or as you titrate up, this page on 5mg side effects gives a useful comparison point for what changes at the next dose.

If you have not yet started treatment and are weighing up your options, you are welcome to start a free consultation with our prescribers, reviewed the same day by a named clinician, never by an automated system.